Ozempic is a once-weekly injectable prescription medication used primarily to manage type 2 diabetes. Its active ingredient, semaglutide, belongs to a class of drugs called GLP-1 receptor agonists, which mimic a natural gut hormone that regulates blood sugar and appetite. While it has become widely known for its weight loss effects, Ozempic is not FDA-approved for weight loss on its own. A separate, higher-dose version of the same drug, called Wegovy, carries that approval.
How Ozempic Works in Your Body
After you eat, your gut naturally releases a hormone called GLP-1 that tells your pancreas to produce insulin. Semaglutide, the drug in Ozempic, is structurally 94% identical to that natural hormone, so it activates the same receptors. But unlike the natural version, which breaks down within minutes, semaglutide stays active in the body for about a week. That’s why one injection covers seven days.
Once it binds to GLP-1 receptors, Ozempic triggers several effects at once. It signals your pancreas to release more insulin, but only when blood sugar is elevated, which lowers the risk of dangerous blood sugar drops. It also slows the rate at which food leaves your stomach, so glucose enters your bloodstream more gradually after meals. At the same time, it reduces the release of glucagon, a hormone that raises blood sugar.
The appetite and weight effects come from its action in the brain. Semaglutide interacts with GLP-1 receptors in the hypothalamus, the brain region that controls hunger. This interaction reduces food cravings, dampens hunger signals, and increases feelings of fullness. For many people, the result is eating significantly less without feeling like they’re forcing themselves to diet.
What Ozempic Is Approved to Treat
The FDA has approved Ozempic for three specific uses in adults: managing type 2 diabetes, reducing cardiovascular risk in people with type 2 diabetes and heart disease, and improving kidney and cardiovascular health in people with type 2 diabetes and chronic kidney disease. It is not approved as a standalone weight loss medication.
That distinction matters because Wegovy, which contains the same active ingredient, is the version approved for weight management. Wegovy’s maximum dose is 2.4 mg per week compared to Ozempic’s 2 mg, and it’s approved for adults and children 12 and older with obesity or overweight. When doctors prescribe Ozempic specifically for weight loss, they are prescribing it “off-label,” meaning outside its official approved use.
How It’s Taken
Ozempic comes as a pre-filled pen that you inject under the skin of your abdomen, thigh, or upper arm once a week, on the same day each week. The dose starts low and increases gradually to reduce side effects. You begin at 0.25 mg weekly for the first four weeks, then increase to 0.5 mg. From there, your doctor may raise the dose to 1 mg or eventually to the maximum of 2 mg, depending on how your blood sugar responds and how you tolerate the medication.
Before its first use, an Ozempic pen needs to be refrigerated between 36°F and 46°F. Once you start using a pen, it stays good for 56 days whether you keep it in the fridge or at room temperature (up to 86°F). It should never be frozen or exposed to temperatures below 36°F.
Common Side Effects
The most frequent side effects are gastrointestinal. Nausea is by far the most commonly reported, followed by vomiting, diarrhea, constipation, and abdominal pain. These effects tend to be worst during the first few weeks and when the dose increases, then gradually improve as your body adjusts. The slow dose escalation schedule exists specifically to minimize these symptoms.
For most people, nausea is manageable and temporary. Eating smaller meals, avoiding greasy or heavy foods, and staying hydrated can help. Some people, however, find the GI effects severe enough that they need to stay at a lower dose longer or stop the medication altogether.
Serious Risks and Warnings
Ozempic carries a boxed warning, the FDA’s most serious safety label, about a potential risk of thyroid tumors. In animal studies, semaglutide caused thyroid C-cell tumors in rodents. Whether this translates to humans is still unknown. Because of this uncertainty, Ozempic is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or a rare condition called Multiple Endocrine Neoplasia syndrome type 2.
Pancreatitis (inflammation of the pancreas) is another serious but less common concern. Symptoms include severe abdominal pain that doesn’t go away, sometimes radiating to the back and accompanied by vomiting. Ozempic is also contraindicated for anyone who has had a serious allergic reaction to semaglutide.
Cardiovascular Benefits
Beyond blood sugar control, Ozempic has shown meaningful heart benefits. A meta-analysis of 17 studies covering more than 40,000 patients found that semaglutide reduced the risk of major adverse cardiovascular events, a composite measure that includes heart attack, stroke, and cardiovascular death, by 18%. The benefit was especially pronounced in people who also had chronic kidney disease: a 24% reduction in cardiovascular death and a 27% reduction in major cardiovascular events in that group.
These findings are part of why the FDA expanded Ozempic’s approved uses beyond simple blood sugar management. For people with type 2 diabetes who are also at elevated heart or kidney risk, the cardiovascular protection adds a meaningful layer of benefit on top of glucose control.
Ozempic vs. Wegovy
Since both contain semaglutide, people often confuse these two medications. The core differences are dose and labeling. Ozempic tops out at 2 mg per week and is approved for type 2 diabetes and related cardiovascular and kidney risk. Wegovy goes up to 2.4 mg per week as an injectable (and up to 25 mg as an oral pill) and is approved for weight management, liver disease related to metabolic dysfunction, and cardiovascular risk reduction in people with obesity and heart disease.
If your primary goal is weight loss without a type 2 diabetes diagnosis, Wegovy is the version specifically studied and approved for that purpose. Insurance coverage, availability, and cost often influence which one gets prescribed in practice, but the intended medical uses are distinct.